Vitrafy Life Sciences (ASX: VFY) reported strong final Phase II in-vitro platelet cryopreservation results from its study with the United States Army Institute of Surgical Research, with all tested protocols exceeding existing regulatory and quality benchmarks for platelet use in humans. Vitrafy’s 3% DMSO no-wash protocol achieved 94% post-thaw recovery while outperforming alternative approaches across clot strength and platelet receptor retention, reinforcing the commercial potential of its decentralised cryopreservation platform across emergency response, regional healthcare and military settings.

Tetratherix (ASX: TTX) completed a $15m placement and announced an additional Share Purchase Plan to raise up to $2m. The proceeds support the company's transition to commercialisation in 2026, allowing the company to expand its strategic partnership ecosystem and embed a comprehensive customer success infrastructure.

Appen (ASX: APX) shares rose up to 11% last Friday after the Company reaffirmed FY26 guidance at its AGM, targeting revenue of $270–300 million and underlying EBITDA margins of ~5–10%, while highlighting continued momentum in generative AI-related work across both Appen Global and Appen China. The Company outlined strong growth in high-value areas including robotics, coding model evaluation, reinforcement learning and multilingual AI, with GenAI contributing 44.1% of Q4 FY25 revenue.

Shaw and Partners initiated coverage on Atomic Eagle (ASX: AEU) with a BUY recommendation and a price target of $1.40/sh, upside of nearly 270% on AEU’s current price. “In our view Atomic Eagle offers investors an attractive entry point to a coming uranium super-cycle. We see the potential for uranium to at least reach US$200/lb in a coming super-cycle, before reverting to a long-term sustainable price of US$120/lb (2026 real $) next decade. We note that on our modelling, Atomic Eagle is one of the cheapest uranium equities on the ASX trading at an EV/Resource of just US$1.70/lb, and an implied uranium price of just US$65/lb,” the report said. The company also reported results from ongoing close-spaced ground radiometric surveys conducted during Q2-2026 at the Muntanga North exploration area within its 100%-owned Muntanga Uranium Project in Zambia.

Many Peaks Minerals (ASX: MPK) completed a A$27.5 million equity raise, securing strong support from new and existing institutional, professional and sophisticated investors. The placement includes approximately 30.6 million new fully paid ordinary shares issued at A$0.90 per share, positioning the Company with more than A$33 million at closing to accelerate growth across its Côte d’Ivoire project portfolio. Funding will support the rapid advancement of the Ferké Gold Project following the recently announced inaugural mineral resource estimate of 1.32Moz at 1.54g/t gold at Ouarigue. Covered by Mining.com.au.

Metal Powder Works (ASX: MPW) extended its contract with Westinghouse Electric Company (WEC), a global leader in nuclear energy. In the next phase of collaboration, which is expected to take three months, MPW will continue to advance and scale its ability to make powder for WEC which can improve WEC’s end-product performance and advance the Technology Readiness Level (TRL) of components under development, supporting WEC’s broader initiatives in advanced manufacturing and materials innovation for the nuclear energy sector.

Advanced Innergy Holdings (ASX: AIH) released its H1 FY26 results, recording $157.9m in revenue and gross margins of 36.8% (+11.4% vs pcp). Importantly, a new multi-year EV battery protection framework agreement was signed, validating AIH’s technical capability and continuing to expand its portfolio of proprietary products and technologies. The company reaffirmed its FY26 guidance with revenue projections of $387.9m and underlying EBITDA of $62.3m.

Dicker Data (ASX: DDR) surged more than 14% after exceeding guidance expectations in a strong FY26 trading update delivered at its AGM. Unaudited gross revenue grew 13.4% to $1.27 billion across the first four months of FY26, driven by elevated end-point, software and data centre refresh demand. The Company's margin improvement on the sale of existing inventory during the period saw unaudited net profit before tax rise 45.5% to $47.3 million.

NWR will host its next Melbourne Resources Lunch on Thursday 4 June at QT Melbourne, featuring presentations by Ionic Rare Earths (ASX: IXR), Canadian Phosphate (ASX: CP8), Tarrina Resources (ASX: TR8), and Krakatoa Resources (ASX: KTA), with a keynote presentation from Daniel Seeney, CIO of FiveRock Asset Management.

Click here to RSVP

The Gold Coast Investment Showcase hosted by RIU Vertical Events will be held at the JW Marriott Gold Coast Resort & Spa on 11 & 12 June 2026.

This event brings together ASX listed Resources, Energy, Tech, Biotech & Medtech companies, providing a range of investment opportunities.

CLICK HERE TO VIEW THE PROGRAMME

CLICK HERE TO BOOK YOUR FREE PASS

AI is moving beyond prompting and into orchestration. On the latest episode of Vantage Point, David Brudenell returns to discuss the evolution of Decidr AI, an AI infrastructure company designed to sit above major models including OpenAI, Anthropic and open-source systems, orchestrating them into structured business workflows.

The conversation explores what David calls the “sovereign era of AI”, where governance, accountability and visibility are becoming just as important as capability itself. We also discuss the shift from prompting to tasks, Decidr’s approach to improving AI accuracy and cost efficiency, the acquisition of SugarWork and why protecting institutional knowledge may become one of the defining competitive advantages of the AI era.

Spotify | Youtube

Longspur Research released an updated research note on Provaris Energy (ASX: PV1) with a Central Case valuation of $0.11 per share, split between hydrogen ($0.07) and CO₂ ($0.04 per share), with its latest update introducing the CO₂ opportunity and highlighting a second commercial opportunity for Provaris and a valuation scenario based on the JDA with Yinson and development of the full CCS supply chain for Norway now based on the Provaris tank. "We think the adding of a CO₂ tank to the Provaris offering has not been fully appreciated by the market. With countries such as Norway moving ahead with the development of carbon sequestration, the need for solutions such as that provided by Provaris become immediate. With committed partner funding development, we see the CO₂ opportunity as providing near term monetisation for the Provaris IP and complementing the large-scale hydrogen tank opportunity. Our revised central case valuation of A$0.11 includes A$0.04 for the initial CO₂ projects illustrating the value of this to the company as a whole." RaaS also released an updated report, highlighting that Provaris is setting up for an important September quarter, and with an NAV range on a per share basis is $0.09-$0.16/share with a mid-point of $0.13/share.

Evolution Capital initiated coverage on Bioxyne Limited (ASX: BXN) with a Speculative Buy recommendation and a target price of A$0.15 per share. The forecast takes into account softer market conditions in Australia and possible changes to telemedicine regulations in Germany. The A$0.15 target price is supported by comparisons with similar companies and recent industry transactions, placing Bioxyne toward the higher end of those valuation ranges.

RaaS upgraded its valuation for Mastermyne (ASX: MYE) by 17% to $0.41/share, primarily reflecting the roll-forward of the valuation to FY27 earnings, which remained broadly unchanged following MYE’s improved FY26 trading update. RaaS believes the combination of a strong $461m order book, an expanded $1.3bn opportunity pipeline including $593m in near-term opportunities, and a growing net cash position supports their view that MYE remains materially undervalued.

Petra Capital released updated research on Element 25 Limited (ASX: E25) with a BUY recommendation and a $1.59 price target, implying ~590% upside to the current share price of $0.23. Petra said E25 is “set to deliver into a strengthening Mn market” as it advances the fully permitted Butcherbird Manganese Project in WA while reviewing timing for its Louisiana HPMSM refinery. The report highlighted growing demand for manganese rich battery chemistries, noting the shift from LFP to LMFP cathodes, alongside E25’s strategic positioning through its US Department of Energy grant and offtake financing commitments from GM and Stellantis.

GBA Capital released an updated Company Snapshot on ECS Botanics (ASX: ECS) following a site visit to ECS’s medicinal cannabis facility in northern Victoria which left GBA increasingly constructive on the company. The visit reinforced GBA's view that ECS is moving from build phase to monetisation, with quality systems and pharmaceutical-grade manufacturing standards that give it a credible way to compete on more than price. 

METALS AND MINING

Raptor Metals (ASX: RAP) reported its first assay results from the initial five holes of a 2,126m diamond drilling program at its flagship Chester Copper Project, with multiple broad copper-rich intercepts, including: 25.05m @ 2.06% CuEq (1.2% Cu), including 11.02m @ 1.98% Cu from 53.22m and 7m @ 1.29% Cu from 13m, 30m @ 1.44% CuEq (1.05% Cu), including 3.58m @ 2.91% Cu from 11.55m and 3.16m @ 2.8% Cu from 82.64m. Drilling validated Raptor’s geological model, with consistent high-grade copper VMS mineralisation from surface and copper-rich stringer zones confirming strong continuity across the MRE and highlighting further resource growth potential at Chester. Covered by ShareCafe, Stocks Down Under & Investing News.

Jameson Resources (ASX: JAL) achieved a key environmental milestone at its Crown Mountain Coking Coal Project in British Columbia, Canada, with the Environmental Assessment Office issuing it with the Section 27 Notice, confirming completion of the Environmental Application Review. With this milestone, Crown Mountain becomes Canada’s only steelmaking coal project to reach the final environmental assessment stage at both a provincial and federal level. Jameson’s next step will be to submit the Final Revised Environmental Application, expected in October 2026.

Kalamazoo Resources (ASX: KZR) identified growth potential at the Peake deposit to extend the mine life of the Ashburton Gold Project in WA, with a review of the underground mineral resource confirming upside for expansion at depth and along strike. Additionally, an underground exploration target has been reported at the Peake Deposit targeting high-grade extensions below and beyond the current resource. These developments demonstrate potential for further gold ounces and a mine life extension currently not included in the Ashburton Pre-Feasibility Study. Covered by The West Australia and Mining.com.au.

Midas Minerals (ASX: MM1) executed a Binding Heads of Agreement for the sale of the Newington Project in WA. The sale of Newington will allow the company to continue its focus at the Otavi Copper-Gold Project in Namibia, where it has accelerated discovery and resource drilling, and is on track to deliver an updated Mineral Resource Estimate for the T-13 deposit later in 2026. The company was also discussed in Stockhead by journalist Barry Fitzgerald: “Newsflow from this one is going to be good as it gets, with the high-grade nature of the prospects/deposits having particular appeal to investors in a bull copper market."

Tarrina Resources (ASX: TR8) extended the Christmas Gift gold anomaly by 1.16km, with recent soil sampling identifying 35 gold, zinc and copper targets across the project area. High priority targets include the historic McLeod’s Shaft prospect and a new 1.86g/t Au surface soil result 2km north-west of the Christmas Gift mine in previously unexplored ground. The results highlight potential for the mineralised strike to extend more than 4km north-south, with final gold and base metal assays from recent diamond drilling expected in June. Covered by The Australian and Proactive.

Desert Metals (ASX: DM1) defined a new high-priority gold target at Tiogo North following a 1,774-sample soil program at the Tengrela South Project in Côte d’Ivoire. Soil sampling returned a peak result of 617ppb gold and confirmed the Tiogo gold corridor now extends semi-continuously for more than 5.5km in strike, with only 1.5km drill tested to date. The new Tiogo North anomaly extends more than 3km north of previous drilling and will be tested in the next phase of aircore drilling, alongside planned infill, step-out and deeper RC and diamond drilling at Tiogo.

Aurum Resources (ASX: AUE) received three environmental approval certificates for its 3.22Moz Boundiali Gold Project in Côte d’Ivoire, marking a major de-risking milestone on the path to mining licence approval. The approvals cover all three mining licence application areas across 572.67km² and follow a 12-month environmental and social assessment process. Aurum’s Boundiali PFS remains on track for delivery this quarter, with the DFS targeted for Q4 CY2026, supported by 16 company-owned diamond rigs and a A$61 million cash balance at 31 March 2026. Covered by Business News.

American Tungsten & Antimony (ASX: AT4) defined a system-scale tungsten anomaly at the Tennessee Mountain Project in Nevada, with surface sampling confirming high-grade tungsten and molybdenum mineralisation ahead of its maiden drill program. Channel samples returned up to 4,713ppm W (0.59% WO₃) over 1.0m and 4,191ppm W (0.53% WO₃) over 2.0m, while rock chip sampling returned up to 20,693ppm Mo (2.07% Mo), supporting the interpretation of a fertile W-Mo skarn system open along strike and at depth. AT4 has now designed a 29-hole, ~3,000m maiden drill program to test depth and lateral extensions of mineralisation at the historic Garnet Mine. Covered by Stockhead.

Auric Mining (ASX: AWJ) reported an updated Mineral Resource Estimate (MRE) for Munda, along with the latest grade control drilling results from the Munda Starter Pit in WA. The in-situ Mineral Resource for the Munda Gold Deposit (Indicated and Inferred) was re-estimated at 4.20 Mt at 1.43 g/t gold, for 192,000 ounces of gold. After accounting for recent mining depletion of approximately 10,000 ounces, the updated resource represents a 32% increase compared with the December 2024 estimate. Covered by BullsNBears, Small Caps & MiningNews.

Element 25 (ASX: E25) awarded key long-term mining and ore haulage contracts for its Butcherbird Expansion Project (BBX) in WA to ReGroup Australia, advancing operational readiness for the planned 1.1Mtpa manganese expansion. E25 confirmed offtake discussions are at an advanced stage, with BBX on track for mechanical completion and commissioning in Q1 CY2027. It also commenced a review of its U.S. HPMSM Project execution plan to optimise development timing in response to evolving EV market conditions and emerging battery chemistries. The Company continues to engage constructively with General Motors and Stellantis regarding revised commercial arrangements, while maintaining strong support from strategic partners and the U.S. Department of Energy.

Western Yilgarn (ASX: WYX) identified multiple zones of shallow high-grade gallium mineralisation from re-assayed historical vacuum drill pulps at its Cardea 1 Project in WA’s Darling Range region. Results from 161 drillholes returned several significant near-surface intersections, including 2.5m @ 134.4 g/t Ga₂O₃ from 2m. The results highlight broad shallow gallium mineralisation associated with lateritic and bauxitic horizons across the project area, with mineralisation remaining open in multiple directions. Covered by Stockhead.

Celsius Resources (ASX: CLA) announced that Maharlika Investment Corporation, a Philippine national sovereign wealth fund, had issued a press release with respect to the execution of an Assignment Agreement for the sale and assignment of its loan position under the Omnibus Loan and Security Agreement with Makilala Mining Company Inc. to Equinaire Holdings Limited, a wholly owned subsidiary of Kiri. Covered by The Extractor

Western Ridge Resources (ASX: WRX) expanded its flagship Keystone Project in Nevada, USA, following the staking of an additional 248 Lode Claims in early May 2026. The newly acquired claims add approximately 4,960 acres of ground surrounding the existing Keystone Project, increasing the Company’s landholding in the district by approximately 500%. Western Ridge now holds a dominant land position within the emerging mineralised trend prospective for tungsten, silver and gold. 

INDUSTRIAL

SHAPE Australia (ASX:SHA) has agreed to acquire Australian Professional Shopfitters (APS) for up to $29.4 million, comprising $20.4 million upfront (3.8x FY25 EBITDA) and up to $9 million in earn-outs over two years. The Melbourne-based, vertically integrated retail shopfitting business generated $32.5 million revenue in FY25 with future maintainable EBITDA of ~$5.3 million. The deal is forecast to deliver 5-7% normalised EPS accretion in the first full year. It further strengthens SHAPE’s retail offering (following the Arden Group acquisition), enhances vertical integration and margins, adds repeatable high-volume program work, and supports the group’s diversification and long-term growth trajectory.

BPH Global (ASX: BP8) reported gross sales of A$391,000 for its 12th trading period, representing the Company’s second highest monthly trading result since operations commenced in May 2025. Aggregate gross sales over the first 12 months of trading operations are approximately A$3.33 million.

EMVision Mediacal Devices (ASX: EMV) released positive results from its aeromedical study evaluating EMV’s First Responder Brain scanner in simulated air ambulance conditions. The study demonstrated the device's robustness and diagnostic capability during flights, further de-risking its use in rural, remote, and emergency transport scenarios where rapid stroke diagnosis is critical. These findings strengthen the case for broader deployment of EMVision’s portable technology beyond traditional hospital settings.

This week EMV also announced it will receive the next $1.17 million instalment from its $5 million Industry Growth Program (IGP) grant. The funding supports the commercialisation of its portable electromagnetic brain imaging technology, including the emu™ bedside scanner for hospital use and the First Responder device for pre-hospital and remote settings. This tranche advances key activities such as clinical trials, regulatory progress, manufacturing scale-up, and team expansion.

ENERGY

Hazer Group (ASX: HZR) completed its graphite pelletisation program, producing high-performance pellets without impacting product characteristics. Hazer can now offer graphite in powder or pelletised form, broadening potential applications across steel, construction and industrial sectors globally, while supporting transportation and handling at scale.  

RENEWABLE ENERGY

Provaris Energy’s (ASX: PV1) proprietary liquified CO2 (LCO2) tank design achieved a Concept Selection milestone as part of Yinson Production’s development activities which now include LCO2 carriers and floating terminal solutions.The milestone materially broadens the commercial application of the YP-Provaris LCO2 Tank technology across the carbon capture and storage supply chain. Read the company’s latest investor presentation here.

TECHNOLOGY

AnteoTech (ASX: ADO) signed a Strategic Collaboration and Sales Agreement term sheet with South Korean separator technology company Xerabrid to advance next generation battery separator products aimed at improving battery safety and reducing thermal runaway risk. The collaboration combines Anteo S™ with Xerabrid’s ceramic coated separator technology, manufacturing and testing capabilities, supporting joint product development, customer engagement and commercialisation activities across global battery markets. AnteoTech said demand for Anteo S™ separator products is accelerating globally, with multiple companies in South Korea and the United States currently evaluating the technology, including one customer progressing to pilot-scale testing. Covered by Stockhead.

AnteoTech also expanded its Life Sciences business in Japan through the appointment of Tokyo-listed distributor Cosmo Bio to supply AnteoBind™ and related products across the Japanese diagnostics market. The appointment supports AnteoTech’s strategy to expand ELISA and CLIA immunoassay opportunities using AnteoBind NXT™, with Japan identified as a potential pilot.

Blackpearl Group (ASX: BPG) released its FY26 results, highlighting the Pearl Engines' outperformance compared to other foundational AI models. ARR doubled to $26.8m, driven by $14.3m in net new contracted revenue, including subscription revenue growth of 77% to 13.7m. The company's gross margin improved to 69% and is expected to continue to expand in FY27 and beyond as BPG implemented a fixed cost structure. Looking ahead to FY27, the company targets ARR growth and cash conversion as equally weighted priorities.

Advanced Innergy Holdings (ASX: AIH) reconfirmed FY26 guidance following H1 FY26 revenue of $157.9 million and underlying EBITDA of $24.7 million, with a record $239 million orderbook supporting expectations for a stronger second half. Gross margins improved to 36.8%, driven by operational efficiencies and contributions from higher-margin businesses, while AIH also continued expanding across key growth markets including subsea infrastructure and EV battery protection technologies.  

BIOTECH

Emyria Limited (ASX: EMD) welcomes the Therapeutic Goods Administration’s (TGA) announcement of changes to its recommendations for the Authorised Prescriber (AP) scheme for psychedelic-assisted psychotherapy. 

CORPORATE NEWS

Syrah Resources (ASX: SYR) Chair Samantha Hogg gave an address to last week’s Annual General Meeting following her appointment to the role in December.

Lincoln Minerals (ASX: LML) secured a A$3.1 million strategic placement to fully fund upcoming drilling at the Minbrie Copper Project in South Australia. The placement supports planned air core and follow-up diamond drilling, with a preferred drilling contractor secured and mobilisation scheduled for June 2026.

Bio-Gene (ASX: BGT) secured commitments to raise A$3.21 million through a A$2.71 million placement and partially underwritten Share Purchase Plan to support commercialisation of Flavocide® and Qcide®. Funds will be used to complete remaining studies for Bio-Gene’s first Flavocide® regulatory dossier in Australia and expand Qcide® production to support commercial partner supply agreements. The SPP opens on 2 June 2026, with eligible shareholders able to apply for up to A$15,000 of shares on the same terms as the placement.

PainChek (ASX: PCK) entered binding agreements to raise A$5.5 million by way of the issue of unsecured convertible notes to a small group of existing professional or sophisticated investor-shareholders. The support from these shareholders ensures that PainChek can maintain momentum in its North America expansion.

PainChek also announced the appointment of Lil Bianchi as Non-Executive Chair of the Board. Ms Bianchi brings a proven track record of guiding medical technology companies as they navigate growth inflection points and accelerate global market adoption including the US and Europe. With deep expertise spanning business transformation, AI and SaaS technologies, governance and capital markets, she has helped lead companies through expansion, commercialisation and international growth.

Green Technology Metals (ASX: GT1) provided an update on progress following the transformational A$11.0M recapitalisation, with momentum building across its Ontario, Canada projects. Tranche 1 is now complete, with A$1.6M received, while the A$4.0M entitlement offer has been well supported and tranche 2 is expected to follow pending shareholder approval in June. Work on the Seymour DFS is underway, alongside studies into tantalum and rubidium processing opportunities. At the same time, the company is progressing key management and board appointments to support financing, project delivery and the pathway toward operations.

Sunshine Metals (ASX: SHN) closed its Share Purchase Plan heavily oversubscribed, receiving A$7.7 million in applications. Sunshine elected not to scale back applications, with funds to support the Mt Moss acquisition, Liontown mine start-up, exploration and resource development activities. The Company said June quarter milestones include the Liontown shallow gold Resource upgrade, updated Gold Mining Study and commencement of drilling and geophysical programs at Sybil.

Alice Queen (ASX: AQX) appointed experienced geologist Adrian Hell as Exploration Manager, with plans underway to recommence drilling at its Horn Island Gold Project in North Queensland. Mr Hell previously worked at Horn Island between 2016 and 2022 and brings extensive knowledge of the project’s geology and gold system. Covered by Mining.com.au.

Nexalis Therapeutics (ASX: NX1) signed a binding LOI with Point8 Capital for a replacement funding facility of up to A$53 million to support development of IRX-211 for Breakthrough Cancer Pain, IRX-616a for Panic Disorder and SRX-25 for Treatment-Resistant Depression. The new non-dilutive funding structure replaces Nexalis’ existing Linlithgow Family Office facility, which the Company said had cancelled remaining undrawn commitments. Nexalis said the Point8 facility is structured across three dedicated clinical program sub-facilities and is intended to support continuity of its clinical trial programs.

Syntara (ASX: SNT) will host an investor webinar on 1 June 2026 ahead of the expected June topline data readout from its Phase 2 SNT-4728 trial in isolated REM sleep behaviour disorder (iRBD), a prodromal feature of Parkinson’s disease. The webinar will feature Syntara CEO Gary Phillips, Head of Drug Discovery Dr Wolfgang Jarolimek, Parkinson’s UK’s Dr Lynsey Bilsland and trial Principal Investigator Professor Simon Lewis, with discussion focused on the ongoing study and broader Parkinson’s disease opportunity.

ABC News aired a feature on Bioxyne (ASX: BNX) this week, providing a rare behind-the-scenes look at the company’s operations, including the production line, secure vaults, and the journey to patients undergoing therapy - Inside the legal MDMA and psilocybin magic mushroom trade.

AnteoTech (ASX: ADO) drone battery tech clears commercial cell hurdle covered by The Australian.

IRIS Metals (ASX: IR1) and Everest Metals (ASX: EMC) were highlighted in Stockhead’s recent article Rubidium explained: Why advanced economies are chasing this niche critical mineral.

Locksley Resources (ASX: LKY) is one of the ASX explorers increasing their presence in the Cobar Basin in coverage by Stockhead: ASX explorers flock to the Cobar Basin as hungry mills eye new ore.

American Tungsten & Antimony (ASX: AT4) 'Game changer': Officials announce plans for antimony mine, processing facility in Southern Utah.

Syrah Resources (ASX: SYR) Managing Director’s AGM Presentation

Appen (ASX: APX) CEO’s AGM Presentation

Vitrafy Life Sciences (ASX: VFY) Phase II - USAISR Platelet Results

Avecho Biotechnology (ASX: AVE) Investor Webinar Replay

Auric Mining (ASX: AWJ) 2026 Annual General Meeting Presentation

Blackpearl group (ASX: BPG) FY26 Results Presentation

Advanced Innergy Holdings (ASX: AIH) H1 FY26 Results Presentation

Dicker Data (ASX: DDR) Annual General Meeting 2026 Presentation

Equus Group (ASX: HZR) Investor Presentation

Syntara (ASX: SNT) featured on the ASX Briefs podcast in the episode: How Syntara Builds a Biotech Pipeline with Multiple Shots on Goal

Syntara (ASX: SNT) CEO Gary Phillips reached out to shareholders as the company undertakes a $2 million Share Purchase Plan ahead of a milestone-rich period.

Power Minerals (ASX: PNN) CEO Alistair Stephens joined Matt Michael on LEVRD to discuss the company’s recent Morro do Ferro Project acquisition in Brazil in LEVRD episode: Very high grade rare earth intersections.

Stock Insiders Podcast: AnteoTech (ASX: ADO) targets next-gen battery breakthrough

Kalamazoo Resources (ASX: KZR) Executive Director Ben Ackerman spoke to David Tasker to discuss recent activity and plans ahead at KZR’s Ashburton Gold Project in WA.

Arovella Therapeutics (ASX: ALA) featured on Sky News Australia Business Weekend where Chairman David Williams and Clinical Advisory Board member Dr Salvatore (Sam) Fiorenza highlighted the progress of the Company’s iNKT cell therapy platform as well as the potential for investors.

Sunshine Metals (ASX: SHN) MD Damien Keys joined Matt Michael on LEVRD to discuss the company's strategy to become a North Queensland gold producer through Liontown and the Mt Moss acquisition.